Stay updated on Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial
Sign up to get notified when there's something new on the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page.

Latest updates to the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page
- Check4 days agoChange DetectedFooter branding and navigation elements were removed, including the Moffitt trial website link, sponsor name, and the 'Helpful Links Provided by' header. This changes how the page footer presents branding and navigation but does not alter the study details.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page revision tag was changed from v3.5.3 to v3.5.4. This indicates the ClinicalTrials.gov entry has been refreshed to reflect updates to its content or metadata.SummaryDifference0.1%

- Check41 days agoChange DetectedThe page’s footer/version label was updated from one site revision to the next (v3.5.2 → v3.5.3), indicating a platform release rather than a change to the clinical trial record itself.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be a backend update with no impact on study data or patient-facing content.SummaryDifference0.1%

- Check55 days agoChange DetectedScreenshots show only visual/layout changes with no modification to the study's main content.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded 'Cutaneous neuroendocrine carcinoma' as a related topic and a 'Genetic and Rare Diseases Information Center' resource under the Resources section.SummaryDifference0.2%

Stay in the know with updates to Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivo+Ipi +/- SBRT in Metastatic MCC Clinical Trial page.